Desano’s dolutegravir/lamivudine/tenofovir tablet prequalified

news 2 September 2022

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

  • HA746 - Dolutegravir (Sodium)/Lamivudine/Tenofovir disoproxil fumarate - 50mg/300mg/300mg - Film-coated tablet - Desano Pharmaceuticals Pvt Ltd - INDIA

 

Related Links